RxDoctor Payments Data

Judith Thompson, MD

Surgery · New Braunfels, TXNPI 1053359315

Payments from drug & device makers

$2,253in general payments, 2019–2025

Across 25 payments — averaging $90.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$956
  • Stryker$480
  • Si-bone, Inc.$161
  • Intuitive Surgical$149
  • Amgen$138
  • Johnson & Johnson$120
  • plus $247 from 4 others

What the payments were for

  • Travel & lodging$1,08648%
  • Food & beverage$1,16752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)10$956
Stryker1$480
Si-bone, Inc.1$161
Intuitive Surgical3$149
Amgen1$138
Johnson & Johnson1$120
Boehringer Ingelheim1$111
Myriad Genetic Laboratories, Inc.5$71
Sirius Medical Systems1$38
Merit Medical Systems Inc1$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,253 in reported general payments places this provider in the 45th percentile of 1,830 surgery providers in Texas.

See all surgery providers in Texas

Medicare billing

Part B allowed, 2024
$83,701
Medicare patients
161
Services billed
422

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamoxifen Citrate93$2,039
Exemestane15$1,464
Anastrozole21$401
Tramadol Hcl18$24

Paid to pharmacies, not to this prescriber.

Other surgery in New Braunfels

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →